G S Pharmacia Profile
Key Indicators
- Authorised Capital ₹ 0.75 M
- Paid Up Capital ₹ 0.75 M
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.20 M
- Revenue Growth 83.42%
- Profit Growth 45.66%
- Ebitda 171.42%
- Net Worth -4.42%
- Total Assets 55.13%
About G S Pharmacia
G S Pharmacia Private Limited (GSPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 October 2007 and has a history of 17 years and four months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.75 M and a paid-up capital of Rs 0.75 M.
The company currently has active open charges totaling ₹2.20 M.
Girija Sinha, Bandana Kumari, Prushottam Kumar, and One other member serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397BR2007PTC013210
- Company No.
013210
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at G S Pharmacia?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Pankaj  | Managing Director | 04-Oct-2007 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Girija Sinha | Director | 02-Mar-2009 | Current |
| Bandana Kumari | Director | 01-Dec-2017 | Current |
| Prushottam Kumar | Director | 01-Dec-2017 | Current |
Financial Performance of G S Pharmacia.
G S Pharmacia Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 83.42% increase. The company also saw a substantial improvement in profitability, with a 45.66% increase in profit. The company's net worth dipped by a decrease of 4.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of G S Pharmacia?
In 2017, G S Pharmacia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dev Engicons ( India) Private LimitedGirija Sinha and Deepak Pankaj are mutual person
Charges (Loans)
₹2.20 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2008 | State Bank Of India | ₹2.20 M | Open |
How Many Employees Work at G S Pharmacia?
Unlock and access historical data on people associated with G S Pharmacia, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G S Pharmacia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G S Pharmacia's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
